FOEHR MATTHEW W
Insider CIK 1237556 · RTTR Director · VKTX Director · OABI President and CEO, Director · NONE CLO & Secretary, Director · LGNDD President and COO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OABI OmniAb, Inc. | M Exercise deriv | 2026-04-07 | 2026-04-07 | 36,459 | — | $0 | 309,376 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2026-04-07 | 2026-04-07 | 36,459 | — | $0 | 4,439,736 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2026-04-07 | 2026-04-07 | 19,244 | $1.49 | $28.7K | 4,420,492 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2026-02-18 | 2026-02-18 | 1,562,500 | — | $0 | 1,562,500 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2026-02-18 | 2026-02-18 | 156,250 | — | $0 | 345,835 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2026-02-18 | 2026-02-18 | 58,333 | — | $0 | 189,585 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2026-02-18 | 2026-02-18 | 30,843 | $1.71 | $52.7K | 4,403,277 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2026-02-18 | 2026-02-18 | 58,333 | — | $0 | 4,434,120 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2026-02-17 | 2026-02-17 | 20,754 | $1.70 | $35.3K | 4,375,787 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2026-02-16 | 2026-02-17 | 36,458 | — | $0 | 247,918 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2026-02-16 | 2026-02-17 | 36,458 | — | $0 | 4,396,541 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 20,400 | — | $0 | 20,400 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2026-01-02 | 2026-01-05 | 16,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-02 | 2026-01-05 | 16,000 | $35.11 | $561.8K | 132,036 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2026-01-02 | 2026-01-05 | 16,000 | $3.33 | $53.3K | 148,036 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-05 | 3,150 | — | $0 | 135,186 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2025-12-08 | 2025-12-09 | 13,666 | $1.96 | $26.8K | 4,360,083 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2025-12-07 | 2025-12-09 | 26,554 | — | $0 | 284,376 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2025-12-07 | 2025-12-09 | 26,554 | — | $0 | 4,373,749 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2025-08-26 | 2025-08-26 | 540,540 | $1.85 | $1000.0K | 4,341,987 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2025-04-11 | 2025-04-14 | 20,786 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2025-04-11 | 2025-04-14 | 20,786 | $8.00 | $166.3K | 132,036 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2025-04-07 | 2025-04-07 | 36,458 | — | $0 | 310,930 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2025-04-07 | 2025-04-07 | 19,382 | $2.00 | $38.8K | 3,796,236 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2025-04-07 | 2025-04-07 | 36,458 | — | $0 | 3,815,618 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2025-02-19 | 2025-02-19 | 19,522 | $3.67 | $71.6K | 3,779,160 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2025-02-18 | 2025-02-19 | 1,050,000 | — | $0 | 1,050,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2025-02-18 | 2025-02-19 | 175,000 | — | $0 | 347,388 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2025-02-18 | 2025-02-19 | 13,964 | $3.68 | $51.4K | 3,798,682 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2025-02-16 | 2025-02-19 | 36,458 | — | $0 | 172,388 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2025-02-16 | 2025-02-19 | 36,458 | — | $0 | 3,812,646 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2025-02-15 | 2025-02-19 | 26,549 | — | $0 | 208,846 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2025-02-15 | 2025-02-19 | 26,549 | — | $0 | 3,776,188 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2025-01-21 | 2025-01-22 | 41,811 | $3.24 | $135.5K | 3,749,639 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2025-01-17 | 2025-01-22 | 77,003 | — | $0 | 3,791,450 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-06 | 18,800 | — | $0 | 18,800 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2024-12-09 | 2024-12-10 | 13,634 | $4.13 | $56.3K | 3,714,447 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-12-07 | 2024-12-10 | 26,555 | — | $0 | 235,395 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-12-07 | 2024-12-10 | 26,555 | — | $0 | 3,728,081 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-11-25 | 2024-11-26 | 68,360 | — | $0 | 396,484 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-11-25 | 2024-11-26 | 31,074 | — | $0 | 155,371 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-11-25 | 2024-11-26 | 31,074 | $3.68 | $114.4K | 3,630,240 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-11-25 | 2024-11-26 | 68,360 | $3.75 | $256.4K | 3,698,600 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-06-27 | 2024-06-27 | 18,644 | — | $0 | 186,445 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-06-27 | 2024-06-27 | 41,015 | — | $0 | 464,844 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-06-27 | 2024-06-27 | 18,644 | $3.68 | $68.6K | 3,558,151 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-06-27 | 2024-06-27 | 41,015 | $3.75 | $153.8K | 3,599,166 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2024-05-24 | 2024-05-28 | 240,000 | $4.42 | $1.06M | 3,536,665 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-04-07 | 2024-04-09 | 36,458 | — | $0 | 261,950 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2024-04-07 | 2024-04-09 | 18,477 | $5.31 | $98.1K | 3,170,397 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-04-07 | 2024-04-09 | 36,458 | — | $0 | 3,188,874 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-03-27 | 2024-03-29 | 93,222 | — | $0 | 205,089 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-03-27 | 2024-03-29 | 150,391 | — | $0 | 505,859 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-03-27 | 2024-03-29 | 150,391 | $3.75 | $564.0K | 3,152,416 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-03-27 | 2024-03-29 | 93,222 | $3.68 | $343.1K | 3,002,025 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2024-03-22 | 2024-03-25 | 225,000 | $5.19 | $1.17M | 2,908,803 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2024-02-16 | 2024-02-20 | 656,250 | — | $0 | 656,250 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2024-02-16 | 2024-02-20 | 109,375 | — | $0 | 298,408 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-02-15 | 2024-02-20 | 26,558 | — | $0 | 189,033 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-02-15 | 2024-02-20 | 10,770 | — | $0 | 215,591 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-02-15 | 2024-02-20 | 10,770 | — | $0 | 2,676,164 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2024-02-15 | 2024-02-20 | 5,459 | $5.54 | $30.2K | 2,670,705 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2024-02-15 | 2024-02-20 | 13,460 | $5.54 | $74.6K | 2,683,803 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-02-15 | 2024-02-20 | 26,558 | — | $0 | 2,697,263 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-01-02 | 2024-01-03 | 33,173 | — | $0 | 226,361 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 32,000 | — | $0 | 32,000 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-01-02 | 2024-01-03 | 33,173 | — | $0 | 2,678,615 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2024-01-02 | 2024-01-03 | 13,221 | $6.25 | $82.6K | 2,665,394 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2023-12-12 | 2023-12-13 | 200,000 | $5.05 | $1.01M | 2,645,442 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2023-12-07 | 2023-12-11 | 26,556 | — | $0 | 259,534 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2023-12-07 | 2023-12-11 | 26,556 | — | $0 | 2,454,626 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2023-12-07 | 2023-12-11 | 9,184 | $4.85 | $44.5K | 2,445,442 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2023-11-10 | 2023-11-13 | 95,000 | $4.27 | $405.6K | 2,427,919 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2023-08-14 | 2023-08-15 | 45,000 | $5.48 | $246.6K | 2,332,919 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2023-06-09 | 2023-06-12 | 115,000 | $4.52 | $519.8K | 2,574,009 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2023-05-12 | 2023-05-15 | 440,000 | $3.40 | $1.50M | 2,438,414 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-04-07 | 2023-04-11 | 656,250 | — | $0 | 656,250 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2023-04-07 | 2023-04-11 | 109,375 | — | $0 | 1,998,414 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2023-02-15 | 2023-02-17 | 3,725 | $3.80 | $14.2K | 1,893,216 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2023-02-15 | 2023-02-17 | 9,184 | $3.80 | $34.9K | 1,896,941 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2023-02-15 | 2023-02-17 | 4,177 | $3.80 | $15.9K | 1,889,039 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2023-01-03 | 2023-01-05 | 79,665 | — | $0 | 1,906,125 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2022-12-28 | 2022-12-30 | 11,624 | $3.66 | $42.5K | 1,826,460 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2022-12-12 | 2022-12-14 | 150,000 | $3.77 | $565.5K | 1,838,084 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-12-07 | 2022-12-09 | 298,311 | — | $0 | 298,311 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2022-12-01 | 2022-12-05 | 17,266 | $3.35 | $57.8K | 1,688,084 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2022-11-30 | 2022-12-01 | 300,000 | $3.39 | $1.02M | 1,705,350 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2022-11-09 | 2022-11-09 | 100,000 | $2.76 | $276.0K | 1,405,350 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2022-11-01 | 2024-04-23 | 1,431,618 | — | $0 | 3,296,665 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | D To issuer deriv | 2022-11-01 | 2022-11-03 | 34,214 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 29,012 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 11,475 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 17,711 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 60,878 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 29,861 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 60,878 | — | $0 | 60,878 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 55,222 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 21,271 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 22,660 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 35,258 | — | $0 | 0 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 270,595 | — | $0 | 270,595 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 172,768 | — | $0 | 172,768 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 111,038 | — | $0 | 111,038 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 104,231 | — | $0 | 104,231 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 86,790 | — | $0 | 86,790 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 146,325 | — | $0 | 146,325 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 142,168 | — | $0 | 142,168 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 298,311 | — | $0 | 298,311 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 56,233 | — | $0 | 56,233 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | D To issuer | 2022-11-01 | 2022-11-03 | 20,304 | — | $0 | 162,187 | SEC↗ |
| NONE OmniAb Operations, Inc. | A Award | 2022-11-01 | 2022-11-03 | 26,193 | — | $0 | 212,362 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer | 2022-11-01 | 2022-11-03 | 212,362 | — | $0 | 0 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2022-11-01 | 2022-11-03 | 1,305,350 | — | $0 | 1,305,350 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-06-10 | 2022-06-14 | 9,137 | — | $0 | 182,491 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2022-05-13 | 2022-05-13 | 2,500 | $82.76 | $206.9K | 173,354 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-05-05 | 2022-05-09 | 34,214 | — | $0 | 34,214 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | P Buy | 2022-05-02 | 2022-05-03 | 45,000 | $2.47 | $111.2K | 111,250 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-02-15 | 2022-02-16 | 1,222 | $123.68 | $151.1K | 171,944 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-02-15 | 2022-02-16 | 1,090 | $123.68 | $134.8K | 170,854 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-02-15 | 2022-02-16 | 1,234 | $123.68 | $152.6K | 173,166 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-01-26 | 2022-01-28 | 7,396 | — | $0 | 179,525 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-01-26 | 2022-01-28 | 5,604 | — | $0 | 172,129 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-01-26 | 2022-01-28 | 3,188 | $113.68 | $362.4K | 174,400 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-01-26 | 2022-01-28 | 1,937 | $113.68 | $220.2K | 177,588 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 22,000 | — | $0 | 22,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-11-11 | 2021-11-12 | 1,028 | — | $0 | 24,348 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-11-11 | 2021-11-12 | 11,160 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2021-11-11 | 2021-11-12 | 11,160 | $163.02 | $1.82M | 166,525 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-11-11 | 2021-11-12 | 11,160 | $21.92 | $244.6K | 177,685 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-11-11 | 2021-11-12 | 1,028 | $100.38 | $103.2K | 166,525 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-08-04 | 2021-08-05 | 1,142 | — | $0 | 25,938 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-08-04 | 2021-08-05 | 8,840 | — | $0 | 11,160 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-08-04 | 2021-08-05 | 1,142 | $85.79 | $98.0K | 165,497 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2021-08-04 | 2021-08-05 | 8,840 | $109.67 | $969.5K | 164,355 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-08-04 | 2021-08-05 | 8,840 | $21.92 | $193.8K | 173,195 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | P Buy | 2021-06-10 | 2021-06-10 | 20,000 | $5.69 | $113.8K | 66,250 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-05-28 | 2021-06-01 | 1,755 | — | $0 | 40,358 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-05-28 | 2021-06-01 | 1,755 | $56.26 | $98.7K | 164,355 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | G Gift | 2021-05-28 | 2021-06-01 | 2,500 | — | $0 | 162,600 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | X Exercise deriv | 2021-03-22 | 2021-03-25 | 20,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | X Exercise | 2021-03-22 | 2021-03-25 | 20,000 | $1.50 | $30.0K | 46,250 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-15 | 2021-02-18 | 1,222 | $172.46 | $210.7K | 165,100 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-15 | 2021-02-18 | 1,235 | $172.46 | $213.0K | 166,322 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-15 | 2021-02-18 | 641 | $172.46 | $110.5K | 167,557 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-02-04 | 2021-02-05 | 1,000 | — | $0 | 63,210 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-02-04 | 2021-02-05 | 44,547 | — | $0 | 20,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-02-04 | 2021-02-05 | 44,547 | $21.92 | $976.5K | 212,745 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-02-04 | 2021-02-05 | 1,000 | $74.42 | $74.4K | 168,198 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2021-02-04 | 2021-02-05 | 44,547 | $176.86 | $7.88M | 168,198 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2021-02-03 | 2021-02-05 | 13,136 | — | $0 | 13,136 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-02-03 | 2021-02-05 | 6,595 | — | $0 | 167,198 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-01-25 | 2021-01-27 | 2,911 | — | $0 | 158,324 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-01-25 | 2021-01-27 | 1,053 | $156.01 | $164.3K | 157,271 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-01-25 | 2021-01-27 | 2,272 | $156.01 | $354.5K | 160,603 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-01-25 | 2021-01-27 | 5,604 | — | $0 | 162,875 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 22,000 | — | $0 | 22,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-08-24 | 2020-08-25 | 78 | — | $0 | 64,547 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-08-24 | 2020-08-25 | 78 | $21.92 | $1.7K | 155,491 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2020-08-24 | 2020-08-25 | 78 | $110.89 | $8.6K | 155,413 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-08-21 | 2020-08-25 | 7,225 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-08-21 | 2020-08-25 | 790 | — | $0 | 64,210 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-08-21 | 2020-08-25 | 7,225 | $14.47 | $104.5K | 162,638 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-08-21 | 2020-08-25 | 790 | $74.42 | $58.8K | 155,413 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2020-08-21 | 2020-08-25 | 7,225 | $112.88 | $815.6K | 155,413 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2020-06-30 | 2020-06-30 | 13,000 | $7.35 | $95.5K | 26,250 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | D To issuer deriv | 2020-04-10 | 2020-04-23 | 38,461 | — | $0 | 0 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award | 2020-04-10 | 2020-04-23 | 38,461 | — | $0 | 138,635 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-03-13 | 2020-03-13 | 2,000 | — | $0 | 64,625 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-03-13 | 2020-03-13 | 2,000 | $21.92 | $43.8K | 157,449 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-02-27 | 2020-02-27 | 1,706 | — | $0 | 66,625 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-02-27 | 2020-02-27 | 7,225 | — | $0 | 7,225 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2020-02-27 | 2020-02-27 | 7,225 | $110.00 | $794.8K | 153,743 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-02-27 | 2020-02-27 | 1,706 | $21.92 | $37.4K | 155,449 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-02-27 | 2020-02-27 | 7,225 | $14.47 | $104.5K | 160,968 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2020-02-15 | 2020-02-18 | 1,170 | $97.23 | $113.8K | 153,743 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2020-02-15 | 2020-02-18 | 447 | $97.23 | $43.5K | 154,913 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2020-02-15 | 2020-02-18 | 869 | $97.23 | $84.5K | 155,360 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-02-14 | 2020-02-18 | 7,225 | — | $0 | 14,450 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2020-02-14 | 2020-02-18 | 7,225 | $95.84 | $692.4K | 156,229 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-02-14 | 2020-02-18 | 7,225 | $14.47 | $104.5K | 163,454 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2020-02-13 | 2020-02-18 | 33,210 | — | $0 | 33,210 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-02-13 | 2020-02-18 | 496 | — | $0 | 68,331 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2020-02-13 | 2020-02-18 | 7,396 | — | $0 | 156,229 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-02-13 | 2020-02-18 | 496 | $21.92 | $10.9K | 148,833 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | C Conversion deriv | 2020-01-21 | 2020-04-23 | 100 | — | $0 | 0 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | C Conversion | 2020-01-21 | 2020-04-23 | 76,923 | — | $0 | 100,174 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2020-01-15 | 2020-01-17 | 12,000 | — | $0 | 12,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 22,000 | — | $0 | 22,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-12-20 | 2019-12-26 | 2,210 | $105.87 | $234.0K | 146,868 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-12-20 | 2019-12-26 | 4,458 | — | $0 | 149,078 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-12-20 | 2019-12-26 | 1,444 | $105.87 | $152.9K | 148,337 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-12-20 | 2019-12-26 | 2,913 | — | $0 | 149,781 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-11-12 | 2019-11-13 | 1,001 | — | $0 | 68,827 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-11-12 | 2019-11-13 | 1,001 | $21.92 | $21.9K | 144,620 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-09-05 | 2019-09-05 | 1,005 | — | $0 | 69,828 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-09-05 | 2019-09-05 | 1,005 | $21.92 | $22.0K | 143,619 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-08-12 | 2019-08-13 | 1,163 | — | $0 | 70,833 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-08-12 | 2019-08-13 | 1,163 | $21.92 | $25.5K | 142,614 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-06-11 | 2019-06-12 | 1,004 | — | $0 | 71,996 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-06-11 | 2019-06-12 | 1,004 | $21.92 | $22.0K | 141,451 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-03-14 | 2019-03-15 | 14,894 | — | $0 | 15,001 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-03-14 | 2019-03-15 | 14,894 | $9.97 | $148.5K | 140,447 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-02-15 | 2020-04-24 | 938 | $120.86 | $113.4K | 124,615 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-02-15 | 2020-04-24 | 642 | $120.86 | $77.6K | 122,727 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-02-15 | 2020-04-24 | 1,246 | $120.86 | $150.6K | 123,369 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2019-02-11 | 2019-02-13 | 34,181 | — | $0 | 34,181 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-02-11 | 2019-02-13 | 7,472 | — | $0 | 125,553 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2019-02-06 | 2019-02-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-01-23 | 2019-01-25 | 3,715 | — | $0 | 119,365 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-01-23 | 2019-01-25 | 1,284 | $111.78 | $143.5K | 115,650 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-01-23 | 2019-01-25 | 1,284 | $111.78 | $143.5K | 118,081 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-01-23 | 2019-01-25 | 3,547 | — | $0 | 116,934 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2019-01-02 | 2019-01-03 | 22,000 | — | $0 | 22,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-12-12 | 2018-12-12 | 7,999 | — | $0 | 29,895 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-12-12 | 2018-12-12 | 7,999 | $9.97 | $79.8K | 113,387 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | P Buy deriv | 2018-11-05 | 2018-11-07 | 38,461 | — | $0 | 38,461 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | P Buy deriv | 2018-11-05 | 2018-11-07 | 100 | — | $0 | 100 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-10-01 | 2018-10-02 | 2,088 | — | $0 | 37,894 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-10-01 | 2018-10-02 | 12,000 | — | $0 | 21,675 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-10-01 | 2018-10-02 | 12,000 | $273.88 | $3.29M | 105,388 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-10-01 | 2018-10-02 | 12,000 | $14.47 | $173.6K | 117,388 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-10-01 | 2018-10-02 | 2,088 | $9.97 | $20.8K | 105,388 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-09-04 | 2018-09-05 | 12,000 | — | $0 | 33,675 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-09-04 | 2018-09-05 | 1,044 | — | $0 | 39,982 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-09-04 | 2018-09-05 | 12,000 | $14.47 | $173.6K | 115,300 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-09-04 | 2018-09-05 | 1,044 | $9.97 | $10.4K | 103,300 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-09-04 | 2018-09-05 | 12,000 | $255.01 | $3.06M | 103,300 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | P Buy | 2018-08-17 | 2018-08-20 | 19,751 | $2.04 | $40.3K | 54,751 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | P Buy | 2018-08-17 | 2018-09-19 | 19,751 | $2.04 | $40.3K | 23,251 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-05-10 | 2018-05-11 | 1,055 | — | $0 | 41,026 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-05-10 | 2018-05-11 | 8,881 | — | $0 | 45,675 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-05-10 | 2018-05-11 | 1,055 | $9.97 | $10.5K | 102,256 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-05-10 | 2018-05-11 | 8,881 | $167.63 | $1.49M | 101,201 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-05-10 | 2018-05-11 | 8,881 | $14.47 | $128.5K | 110,082 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-03-06 | 2018-03-06 | 1,457 | $165.87 | $241.7K | 101,201 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-03-06 | 2018-03-06 | 2,940 | — | $0 | 102,658 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-03-02 | 2018-03-06 | 20,274 | — | $0 | 20,274 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-03-02 | 2018-03-06 | 3,883 | — | $0 | 99,718 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-02-23 | 2018-02-27 | 1,004 | — | $0 | 42,081 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-02-23 | 2018-02-27 | 5,444 | — | $0 | 54,556 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-02-23 | 2018-02-27 | 5,444 | $14.47 | $78.8K | 101,279 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-02-23 | 2018-02-27 | 1,004 | $9.97 | $10.0K | 95,835 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-02-23 | 2018-02-27 | 5,444 | $152.98 | $832.8K | 95,835 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-02-15 | 2018-02-16 | 1,511 | $157.18 | $237.5K | 96,983 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-02-15 | 2018-02-16 | 1,246 | $157.18 | $195.8K | 94,831 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-02-15 | 2018-02-16 | 906 | $157.18 | $142.4K | 96,077 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2018-01-23 | 2018-01-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2018-01-02 | 2018-01-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-12-28 | 2017-12-29 | 5,695 | — | $0 | 101,465 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-12-28 | 2017-12-29 | 2,971 | $138.66 | $412.0K | 98,494 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-08-09 | 2017-08-10 | 850 | — | $0 | 43,085 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-08-09 | 2017-08-10 | 6,100 | — | $0 | 43,935 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-08-09 | 2017-08-10 | 850 | $9.97 | $8.5K | 95,770 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-08-09 | 2017-08-10 | 6,100 | $9.97 | $60.8K | 101,020 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-08-09 | 2017-08-10 | 6,100 | $127.51 | $777.8K | 94,920 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | P Buy | 2017-05-18 | 2017-05-18 | 18,000 | $0.62 | $11.2K | 35,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-05-15 | 2017-05-15 | 2,200 | — | $0 | 50,035 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-05-15 | 2017-05-15 | 2,200 | $9.97 | $21.9K | 94,920 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-05-12 | 2017-05-15 | 5,621 | — | $0 | 52,235 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-05-12 | 2017-05-15 | 5,621 | $9.97 | $56.0K | 98,341 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-05-12 | 2017-05-15 | 5,621 | $112.20 | $630.7K | 92,720 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-03-03 | 2017-03-03 | 2,000 | — | $0 | 57,856 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-03-03 | 2017-03-03 | 2,000 | $9.97 | $19.9K | 92,720 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-03-02 | 2017-03-03 | 6,879 | — | $0 | 59,856 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-03-02 | 2017-03-03 | 6,879 | $103.39 | $711.2K | 90,720 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-03-02 | 2017-03-03 | 6,879 | $9.97 | $68.6K | 97,599 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2017-02-24 | 2017-02-28 | 25,376 | — | $0 | 25,376 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-02-24 | 2017-02-28 | 7,544 | — | $0 | 90,720 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-02-24 | 2017-02-28 | 5,239 | — | $0 | 85,909 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-02-24 | 2017-02-28 | 2,733 | $100.38 | $274.3K | 83,176 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-02-15 | 2017-02-28 | 1,642 | $104.28 | $171.2K | 81,395 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-02-15 | 2017-02-28 | 725 | $104.28 | $75.6K | 80,670 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2017-01-03 | 2017-01-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2016-11-29 | 2016-11-30 | 7,000 | — | $0 | 7,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | P Buy | 2016-11-15 | 2016-11-15 | 13,000 | $1.21 | $15.7K | 39,250 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-08-08 | 2016-08-09 | 4,125 | — | $0 | 66,735 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-08-08 | 2016-08-09 | 4,125 | $9.97 | $41.1K | 83,037 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-08-05 | 2016-08-09 | 12,500 | — | $0 | 70,860 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-08-05 | 2016-08-09 | 12,500 | $9.97 | $124.6K | 91,412 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-08-05 | 2016-08-09 | 12,500 | $122.14 | $1.53M | 78,912 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | P Buy deriv | 2016-04-13 | 2016-04-13 | 20,000 | $0.01 | $200 | 20,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | P Buy | 2016-04-13 | 2016-04-13 | 20,000 | $1.24 | $24.8K | 26,250 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-03-17 | 2016-03-17 | 2,250 | — | $0 | 83,360 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-03-17 | 2016-03-17 | 6,400 | — | $0 | 85,610 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-03-17 | 2016-03-17 | 6,400 | $96.70 | $618.9K | 76,662 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-03-17 | 2016-03-17 | 2,250 | $9.97 | $22.4K | 78,912 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-03-17 | 2016-03-17 | 6,400 | $9.97 | $63.8K | 83,062 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2016-02-15 | 2016-02-16 | 1,642 | $85.97 | $141.2K | 76,662 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2016-02-11 | 2016-02-16 | 27,080 | — | $0 | 27,080 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2016-02-11 | 2016-02-16 | 5,676 | — | $0 | 78,304 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | P Buy | 2016-01-08 | 2016-01-11 | 13,000 | $1.64 | $21.3K | 17,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2016-01-04 | 2016-01-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2015-10-13 | 2015-10-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-06-29 | 2015-06-30 | 2,500 | — | $0 | 92,010 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-06-29 | 2015-06-30 | 2,500 | $9.97 | $24.9K | 72,628 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-06-26 | 2015-06-30 | 12,500 | — | $0 | 94,510 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-06-26 | 2015-06-30 | 12,500 | $100.97 | $1.26M | 70,128 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-06-26 | 2015-06-30 | 12,500 | $9.97 | $124.6K | 82,628 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | P Buy | 2015-06-24 | 2015-06-25 | 4,000 | $5.00 | $20.0K | 4,000 | SEC↗ |